Viruses in cancer treatment
Author:
Open Access
- 10 November 2012
- journal article
- review article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 15 (3) , 182-188
Abstract
Soon after the discovery that viruses cause human disease, started the idea of using viruses to treat cancer. After the initial indiscriminate use, crude preparations of each novel virus in the early twentieth century, a second wave of virotherapy blossomed in the 60s with purified and selected viruses. Responses were rare and short-lived. Immune rejection of the oncolytic viruses was identified as the major problem and virotherapy was abandoned. During the past two decades virotherapy has re-emerged with engineered viruses, with a trend towards using them as tumor-debulking immunostimulatory agents combined with radio or chemotherapy. Currently, oncolytic Reovirus, Herpes, and Vaccinia virus are in late phase clinical trials. Despite the renewed hope, efficacy will require improving systemic tumor targeting, overcoming stroma barriers for virus spread, and selectively stimulating immune responses against tumor antigens but not against the virus. Virotherapy history, viruses, considerations for clinical trials, and hurdles are briefly overviewed.Keywords
This publication has 28 references indexed in Scilit:
- Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced MalignanciesClinical Cancer Research, 2012
- Thunder and Lightning: Immunotherapy and Oncolytic Viruses CollideMolecular Therapy, 2011
- Safety and Clinical Usage of Newcastle Disease Virus in Cancer TherapyBioMed Research International, 2011
- Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral VectorsViruses, 2010
- Intelligent Design: Combination Therapy With Oncolytic VirusesMolecular Therapy, 2010
- Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian CancerCancer Research, 2010
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic MelanomaJournal of Clinical Oncology, 2009
- The History of Tumor VirologyCancer Research, 2008
- History of Oncolytic Viruses: Genesis to Genetic EngineeringMolecular Therapy, 2007
- An Optimized Clinical Regimen for the Oncolytic Virus PV701Clinical Cancer Research, 2007